We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$554M
1-Year Est. Return
29.39%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+29.39%
3 Year Est. Return
+99.7%
5 Year Est. Return
+120.39%
10 Year Est. Return
+406.87%
AUM
$102M
AUM Growth
-$13.3M
(-12%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-16.18%
Top 10 Holdings %
Top 10 Hldgs %
53.41%
Holding
79
New
4
Increased
12
Reduced
30
Closed
9
Top Buys
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$609K |
| 2 |
Microsoft
MSFT
|
+$504K |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$501K |
| 4 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$486K |
| 5 |
Global X MSCI China Consumer Discretionary ETF
CHIQ
|
+$481K |
Top Sells
| 1 |
AGN
Allergan Inc
AGN
|
+$2.23M |
| 2 |
Trimble
TRMB
|
+$1.52M |
| 3 |
MasTec
MTZ
|
+$1.44M |
| 4 |
MRC
MRC Global
MRC
|
+$1.41M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$1.29M |
Sector Composition
| 1 | Technology | 15% |
| 2 | Industrials | 7.77% |
| 3 | Energy | 7.68% |
| 4 | Healthcare | 4.39% |
| 5 | Communication Services | 3% |
Similar funds
LFS
CSIA
TC
SIM
AWA
FFA
CCA
HWM
Bellecapital's Q2 2014 Portfolio in Review
As of Q2 2014, Bellecapital held 79 positions worth $102M, down 12% from $115M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Bellecapital withdrew a net $16.5M in Q2 2014, closing 9 positions and reducing 30 holdings. Its most notable exit was Allergan Inc, an estimated $2.23M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Energy.
Against the trend, Bellecapital opened a new position in PIMCO Enhanced Short Maturity Active Exchange-Traded Fund worth $608K.
- Bellecapital's largest Q2 2014 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 6,000 shares worth $608K.
- Bellecapital added most to Alphabet (Google) Class C in Q2 2014, an estimated $501K increase.
- Bellecapital's biggest Q2 2014 reduction was MasTec, cutting an estimated $1.44M.
- Bellecapital fully exited Allergan Inc in Q2 2014, selling an estimated $2.23M.
- Bellecapital's ten largest holdings make up 53% of its $102M portfolio in Q2 2014.
- Bellecapital opened 4 new positions and closed 9 in Q2 2014.
- Bellecapital's portfolio value fell 12% quarter-over-quarter to $102M.
Based on Bellecapital's 13F filing for Q2 2014, filed 23 Jul 2014.